• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病的新型生物标志物——运动神经元病(MND)、小脑共济失调(CA)和帕金森病(PD)。

Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD).

机构信息

Department of Biochemistry, KGMU, Lucknow 226003, UP, India.

Department of Biochemistry, KGMU, Lucknow 226003, UP, India.

出版信息

Clin Chim Acta. 2018 Oct;485:258-261. doi: 10.1016/j.cca.2018.07.021. Epub 2018 Jul 10.

DOI:10.1016/j.cca.2018.07.021
PMID:30006282
Abstract

Oxygen is the most mandatory component of living organism and it may at times produce highly reactive species, the free radicals, which are destructive to normal living tissues. Degenerative diseases of central nervous system (CNS) are quite common, contributing significantly to morbidity as well as mortality %. In neurodegenerative diseases such as motor neuron disease (MND), Cerebellar Ataxia (CA) and Parkinson's disease (PD), there is no direct evidence for involvement of metals and free radicals in the etiology but circumstantial evidence provides a hypothesis that alteration in metals and free radicals contribute to the pathogenesis of neurodegeneration in these disorders. The aim of the present study was to estimate free radicals cascade i.e. damage caused in terms of malondialdehyde (MDA) and defense system Superoxide dismutase (SOD) and catalase in blood and cerebro-spinal fluid (CSF) of neurodegenerative diseases (MND, CA and PD), to analyze correlation with level of free radical and the clinical variables like age, severity of diseases and duration of illness and any possibility from this clinical parameters to identify a biomarker for diagnosis of neurodegenerative diseases. The level of MDA in CSF was 0.46 ± 0.17 in case of MND, 0.49 ± 0.13 in case of CA and 0.47 ± 0.16 in case of PD as compared control group (0.22 ± 0.06) whereas in blood MDA level was 0.10 ± 0.04 in case of MND, 0.33 ± 0.41 in case of CA and 0.47 ± 0.46 in case of PD as compared control group (0.04 ± 0.03). It was found to be highly significant (p < .001). In CSF and blood both catalase activity was statistically significantly higher as compared to control group of all cases (MND, CA and PD) and SOD activity was statistically significantly lower as compared to control group of all cases. Free radical parameters in human CSF might be a novel biomarker for the early clinical identification of neurodegenerative diseases.

摘要

氧是生物体最必需的成分,它有时会产生具有高反应性的物质,即自由基,这些自由基对正常的活组织具有破坏性。中枢神经系统(CNS)的退行性疾病相当常见,对发病率和死亡率有重大影响。在运动神经元疾病(MND)、小脑共济失调(CA)和帕金森病(PD)等神经退行性疾病中,没有直接证据表明金属和自由基参与了其病因,但间接证据提供了一种假设,即金属和自由基的改变导致了这些疾病的神经退行性发生。本研究的目的是估计自由基级联反应,即通过血液和脑脊液(CSF)中的丙二醛(MDA)和超氧化物歧化酶(SOD)和过氧化氢酶来衡量的损伤,分析其与自由基水平的相关性,并与临床变量如年龄、疾病严重程度和疾病持续时间进行相关分析,以及从这些临床参数中找到一种用于诊断神经退行性疾病的生物标志物的可能性。MND 组 CSF 中 MDA 水平为 0.46±0.17,CA 组为 0.49±0.13,PD 组为 0.47±0.16,与对照组(0.22±0.06)相比,血液 MDA 水平在 MND 组为 0.10±0.04,CA 组为 0.33±0.41,PD 组为 0.47±0.46,与对照组(0.04±0.03)相比,差异有统计学意义(p<.001)。在 CSF 和血液中,所有病例(MND、CA 和 PD)的过氧化氢酶活性均显著高于对照组,所有病例的 SOD 活性均显著低于对照组。人类 CSF 中的自由基参数可能是神经退行性疾病早期临床识别的一种新的生物标志物。

相似文献

1
Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD).神经退行性疾病的新型生物标志物——运动神经元病(MND)、小脑共济失调(CA)和帕金森病(PD)。
Clin Chim Acta. 2018 Oct;485:258-261. doi: 10.1016/j.cca.2018.07.021. Epub 2018 Jul 10.
2
Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.帕金森病及其进展中抗氧化剂水平和脂质过氧化的高度特异性变化:疾病和分期生物标志物及新的药物靶点。
Neurosci Lett. 2016 Mar 23;617:66-71. doi: 10.1016/j.neulet.2016.02.011. Epub 2016 Feb 6.
3
Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1); MN superoxide dismutase (MN SOD) and catalase in the normal human spinal cord and in motor neuron disease.正常人体脊髓和运动神经元疾病中自由基清除酶铜/锌超氧化物歧化酶(SOD1)、锰超氧化物歧化酶(MN SOD)和过氧化氢酶分布的免疫细胞化学研究
J Neurol Sci. 1997 Apr 15;147(2):115-25. doi: 10.1016/s0022-510x(96)05316-6.
4
Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease.
Int J Neurosci. 2003 Aug;113(8):1043-54. doi: 10.1080/00207450390212258.
5
Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease.
Neurosci Lett. 2006 Jul 3;401(3):203-8. doi: 10.1016/j.neulet.2006.03.013. Epub 2006 Apr 4.
6
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.痛风与多发性硬化症、帕金森病和运动神经元病之间的临床关联:记录链接研究。
BMC Neurol. 2015 Feb 28;15:16. doi: 10.1186/s12883-015-0273-9.
7
Blood metal levels and related antioxidant enzyme activities in patients with ataxia telangiectasia.共济失调毛细血管扩张症患者的血液金属水平及相关抗氧化酶活性
Neurobiol Dis. 2015 Sep;81:162-7. doi: 10.1016/j.nbd.2015.04.001. Epub 2015 Apr 13.
8
Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.帕金森病中的铁与氧化应激:损伤生物标志物的观察性研究
PLoS One. 2016 Jan 11;11(1):e0146129. doi: 10.1371/journal.pone.0146129. eCollection 2016.
9
Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.帕金森病患者脑脊液中亚硝酸盐和丙二醛含量
Int J Neurosci. 2006 Dec;116(12):1391-402. doi: 10.1080/00207450500513989.
10
Peripheral blood markers of oxidative stress in Parkinson's disease.帕金森病中氧化应激的外周血标志物
Eur Neurol. 2007;58(2):78-83. doi: 10.1159/000103641. Epub 2007 Jun 12.

引用本文的文献

1
Experimental induction of anti-muscarinic type-3-receptor extracellular loop antibodies by immunization with 4-hydroxy-2-nonenal modified Ro60 and unmodified Ro60.通过用4-羟基-2-壬烯醛修饰的Ro60和未修饰的Ro60免疫诱导抗毒蕈碱3型受体细胞外环抗体
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae114.
2
Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases.金属诱导的神经紊乱和神经退行性疾病中的炎症反应。
Biol Trace Elem Res. 2024 Oct;202(10):4459-4481. doi: 10.1007/s12011-023-04041-z. Epub 2024 Jan 11.
3
Biomarkers of Parkinson's Disease: From Basic Research to Clinical Practice.
帕金森病的生物标志物:从基础研究到临床实践。
Aging Dis. 2024 Aug 1;15(4):1813-1830. doi: 10.14336/AD.2023.1005.
4
Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases.天然抗氧化化合物作为对抗神经退行性疾病的潜在药物工具。
ACS Omega. 2022 Jul 19;7(30):25974-25990. doi: 10.1021/acsomega.2c03291. eCollection 2022 Aug 2.
5
Oxidative Stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the Pathogenesis and Treatment of Aging-related Diseases.氧化应激与 4-羟基-2-壬烯醛(4-HNE):在与衰老相关疾病的发病机制和治疗中的作用。
J Immunol Res. 2022 Mar 23;2022:2233906. doi: 10.1155/2022/2233906. eCollection 2022.
6
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers.揭示帕金森病的病理生理机制:脑脊液生物标志物的作用
Biomark Insights. 2020 Oct 12;15:1177271920964077. doi: 10.1177/1177271920964077. eCollection 2020.
7
Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia.循环外泌体微小RNA作为痴呆的诊断生物标志物
Front Aging Neurosci. 2020 Sep 8;12:580199. doi: 10.3389/fnagi.2020.580199. eCollection 2020.